NCT07670312 Evaluation of XYA02 in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07621718 Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) Status RECRUITING Phase PHASE3
NCT07619391 MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer Status RECRUITING Phase NA
NCT07583771 A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07573215 Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma Status AVAILABLE Phase N/A
NCT07566897 A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07565155 Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency Status NOT_YET_RECRUITING Phase PHASE2
NCT07562152 Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE3
NCT07547033 Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy Status NOT_YET_RECRUITING Phase NA
NCT07491445 Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE3
NCT07488676 A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07478523 FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers Status RECRUITING Phase PHASE2
NCT07349537 Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors Status RECRUITING Phase PHASE1
NCT07090499 A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06892054 Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE1
NCT06698458 Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer Status RECRUITING Phase NA
NCT06483555 Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel Status RECRUITING Phase PHASE1/PHASE2
NCT06399757 A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2